In a recently published randomised trial (ARRIVE) on induction versus expectant management in low-risk nulliparous women, the reduction in the composite of perinatal death or serious neonatal complication by 20% with induction fell just short of statistical significance (95% CI 0.64 to 1.00) [ 56 ]; our findings also support the evidence of benefit for delivery versus expectant management.
← all excerpts
Risks of stillbirth and neonatal death with advancing gestation at term: A systematic review and meta-analysis of cohort studies of 15 million pregnancies.
1
—
—